In the absence of an adaptive immune system, tumor cell-intrinsic PD-1/PD-L1 mediates the resistance to anti-PD-1/PD-L1 antibodies by activating AKT and ERK1/2, which induces tumor growth [83] (Fig. 3C and D). This evidence concerns the gene CD274 and neoplasm.